TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von hippel-lindau tumor suppressor

Urology

Volumn 79, Issue 4, 2012, Pages 966.e1-966.e7

  Shang, Donghao ^a   Liu, Yuting ^b   Yang, Peiqian ^a   Chen, Yongqian ^a   Tian, Ye ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INDUCED; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 84862790132     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.12.011     Document Type: Article

References (30)

1. A.J. Pantuck, A. Zisman, A.S. Belldegrun The changing natural history of renal cell carcinoma J Urol 166 2001 1611 1623
2. F. Huang, E. Newman, D. Theodorescu Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid Cell Growth Differ 6 1995 1635 1642
3. J.F. Tsai, L.Y. Chuang, J.E. Jeng Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma Medicine 76 1997 213 226
4. J. Wang, J. Chen, K. Zhang TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells J Oral Pathol Med 40 2011 762 768
5. S. Ananth, B. Knebelmann, W. Grning Transforming growth factor beta 1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma Cancer Res 59 1999 2210 2216 (Pubitemid 29217687)
6. D. Shang, Y. Liu, Y. Matsui Demethylating agent 5-Aza-2′- deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to cisplatin Urology 71 2008 1220 1225 (Pubitemid 351763776)
7. D. Shang, Y. Liu, Q. Liu Synergy of 5-aza-2′-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and -independent prostate cancer cell lines Cancer Lett 278 2009 82 87
8. D. Shang, N. Ito, T. Kamoto Demethylating agent 5-Aza-2′- deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel Urology 69 2007 1007 1012 (Pubitemid 46670259)
9. J.E. Kim, S.J. Kim, H.W. Jeong RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis Oncogene 22 2003 2045 2053
10. S.W. Park, J.S. Bae, K.S. Kim Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin Exp Mol Med 36 2004 211 219
11. W.M. Linehan, M.I. Lerman, B. Zbar Identification of the von Hippel-Lindau (VHL) gene: its role in renal cancer JAMA 273 1995 564 570
12. W.G. Kaelin Molecular basis of the VHL hereditary cancer syndrome Nat Rev Cancer 2 2002 673 682
13. E.J. Davidowitz, A.R. Schoenfeld, R.D. Burk VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling Mol Cell Biol 21 2001 865 874 (Pubitemid 32104734)
14. M.A. Esteban-Barragn, P. Avila, M. Alvarez-Tejado Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions Cancer Res 62 2002 2929 2936 (Pubitemid 34525781)
15. S. Akhtar, A.J. Bron, N.R. Hawksworth Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy Br J Ophthalmol 85 2001 720 731 (Pubitemid 32554253)
16. D.F. Schorderet, M. Menasche, S. Morand Genomic characterization and embryonic expression of the mouse BigH3 (TGFBI) gene Biochem Biophys Res Commun 274 2000 267 274 (Pubitemid 30614310)
17. S. Endo, T.H. Nguyen, K. Fujiki Leu518Pro mutation of the beta ig-h3 gene causes lattice corneal dystrophy type I Am J Ophthalmol 128 1999 104 106 (Pubitemid 29315774)
18. J.E. Kim, E.H. Kim, E.H. Han A TGF-beta-inducible cell adhesion molecule, betaig-h3, is downregulated in melorheostosis and involved in osteogenesis J Cell Biochem 77 2000 169 178
19. B.H. Lee, J.S. Bae, R.W. Park Betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through αvβ5 integrin Exp Mol Med 38 2006 153 161
20. J. Massagué The TGF-beta family of growth and differentiation factors Cell 49 1987 437 438
21. A.S. Goustin, E.B. Leof, G.D. Shipley Growth factors and cancer Cancer Res 46 1986 1015 1029 (Pubitemid 16048224)
22. K.P. Karey, D.A. Sirbasku Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol Cancer Res 48 1988 4083 4092
23. B.A. Arrick, M. Korc, R. Derynck Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol Cancer Res 50 1990 299 303 (Pubitemid 20041231)
24. D.M. Wiseman, P.J. Polverini, D.W. Kamp Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity Biochem Biophys Res Commun 157 1988 793 800 (Pubitemid 19021249)
25. R.A. Ignotz, J. Massagué Cell adhesion protein receptors as targets for transforming growth factor-beta action Cell 51 1987 189 197
26. C.M. Overall, J.L. Wrana, J. Sodek Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta J Biol Chem 264 1989 1860 1869 (Pubitemid 19051035)
27. R.A. Ignotz, J. Massagué Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix J Biol Chem 261 1986 4337 4345 (Pubitemid 17198877)
28. M.D. Sternlicht, Z. Werb How matrix metalloproteinases regulate cell behavior Annu Res Cell Dev Biol 17 2001 465 516
29. J.H. Kim, C.W. Jung, Y.H. Cho Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma Oncol Rep 13 2005 859 864
30. M. Yao, M. Yoshida, T. Kishida VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma J Natl Cancer Inst 94 2002 1569 1575 (Pubitemid 35277281)